About
Overview
Leadership
Board of Directors
Science
Overview
Pipeline
SMARCA2
CDK9
Precision ADCs
CDK4/6
Discovery Engine
Publications
Clinical Trials
Overview
PRT3789 Trials
PRT2527 Trials
PRT3645 Trials
Investors
Overview
News & Events
News Releases
Events & Presentations
Financials
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Analysts
Governance
Governance Documents
Leadership
Committee Composition
Investor Resources
Investor Faqs
Contact IR
Email Alerts
News
Life at Prelude
Overview
Open Positions
Contact
About
A seasoned team experienced in developing cancer medicines to create a fully integrated oncology company.
About
Overview
Leadership
Board of Directors
Science
Overview
Pipeline
SMARCA2
CDK9
Precision ADCs
CDK4/6
Discovery Engine
Publications
Clinical Trials
Overview
PRT3789 Trials
PRT2527 Trials
PRT3645 Trials
Investors
Overview
News & Events
News Releases
Events & Presentations
Financials
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Analysts
Governance
Governance Documents
Leadership
Committee Composition
Investor Resources
Investor Faqs
Contact IR
Email Alerts
News
Life at Prelude
Overview
Open Positions
Contact
kris-vaddi
About
Overview
Leadership
Board of Directors
Science
Overview
Pipeline
SMARCA2
CDK9
Precision ADCs
CDK4/6
Discovery Engine
Publications
Clinical Trials
Overview
PRT3789 Trials
PRT2527 Trials
PRT3645 Trials
Investors
Overview
News & Events
News Releases
Events & Presentations
Financials
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Analysts
Governance
Governance Documents
Leadership
Committee Composition
Investor Resources
Investor Faqs
Contact IR
Email Alerts
News
Life at Prelude
Overview
Open Positions
Contact